There are SIX FDA approved TNF inhibitor biosimilars in the USA - 3 infliximab (Ixifi, Renflexis, Inflectra), 2 of adalimumab (Amjevita, Cyltezo) and 1 etanercept biosimilar (Erelzi). https://t.co/xxwgvVeEXy https://t.co/ALESYJf0Zi